MUTATIONS IN THE DELTA-7-STEROL REDUCTASE GENE IN PATIENTS WITH THE SMITH-LEMLI-OPITZ-SYNDROME

Citation
Bu. Fitzky et al., MUTATIONS IN THE DELTA-7-STEROL REDUCTASE GENE IN PATIENTS WITH THE SMITH-LEMLI-OPITZ-SYNDROME, Proceedings of the National Academy of Sciences of the United Statesof America, 95(14), 1998, pp. 8181-8186
Citations number
19
Categorie Soggetti
Multidisciplinary Sciences
ISSN journal
00278424
Volume
95
Issue
14
Year of publication
1998
Pages
8181 - 8186
Database
ISI
SICI code
0027-8424(1998)95:14<8181:MITDRG>2.0.ZU;2-Y
Abstract
The Smith-Lemli-Opitz syndrome (SLOS) is an inborn disorder of sterol metabolism with characteristic congenital malformations and dysmorphia s. All patients suffer from mental retardation. Here we identify the S LOS gene as a Delta 7-sterol reductase (DHCR7, EC 1.3.1.21) required f or the de novo biosynthesis of cholesterol, The human and murine genes were characterized and assigned to syntenic regions on chromosomes 11 q13 and 7F5 by fluorescense in situ hybridization, Among the mutations found in patients with the SLOS, are missense (P51S, T93M, L99P, L157 P, A247V, V326L, R352W, C380S, R404C, and G410S), nonsense (W151X), an d splice site (IVS8-1G>C) mutations as well as an out of frame deletio n (720-735 del), The missense mutations L99P, V326L, R352W, R404C, and G410S reduced heterologous protein expression by >90%. Our results st rongly suggest that defects in the DHCR7 gene cause the SLOS.